Picture of Laboratorios Farmaceuticos Rovi logo

ROVI — Laboratorios Farmaceuticos Rovi News Story

0.000.00%
es flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Brief: Rovi To Propose Dividend Of 0.9594 Eur/Shr

Feb 25 (Reuters) - Laboratorios Farmaceuticos ROVI SA ROVI.MC:

TO PROPOSE DIVIDEND OF 0.9594 EUR/SHR

EXPECTS 2026 OPERATING REVENUE TO INCREASE BY BETWEEN A HIGH SINGLE DIGIT AND LOW DOUBLE-DIGIT PERCENTAGE COMPARED TO 2025

Source text: nCNM3DZg3l

Further company coverage: ROVI.MC

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com;))

Recent news on Laboratorios Farmaceuticos Rovi

See all news